-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2010 to Q3 2024.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2024 was $268M, a 45.7% increase year-over-year.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Investing Activities for the twelve months ending September 30, 2024 was $891M, a 6.58% increase year-over-year.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Investing Activities for 2023 was $968M, a 47.6% increase from 2022.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Investing Activities for 2022 was $656M, a 56.9% decline from 2021.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Investing Activities for 2021 was $1.52B, a 76.5% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)